ES2105599T3 - Composiciones que contienen compuestos analogos al aciclovir y analogos nucleosidicos sustituidos por vinilo en la posicion 2' utilizados en el tratamiento de infecciones virales. - Google Patents

Composiciones que contienen compuestos analogos al aciclovir y analogos nucleosidicos sustituidos por vinilo en la posicion 2' utilizados en el tratamiento de infecciones virales.

Info

Publication number
ES2105599T3
ES2105599T3 ES94900549T ES94900549T ES2105599T3 ES 2105599 T3 ES2105599 T3 ES 2105599T3 ES 94900549 T ES94900549 T ES 94900549T ES 94900549 T ES94900549 T ES 94900549T ES 2105599 T3 ES2105599 T3 ES 2105599T3
Authority
ES
Spain
Prior art keywords
vinyl
aciclovir
treatment
compositions containing
viral infections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94900549T
Other languages
English (en)
Inventor
Sai Prasad Sunkara
James Ray Mccarthy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2105599T3 publication Critical patent/ES2105599T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

UN METODO PARA EL TRATAMIENTO DE UN PACIENTE AFECTADO CON UNA INFECCION VIRAL QUE COMPRENDE LA ADMINISTRACION AL PACIENTE DE UNA CANTIDAD ANTIVIRAL EFECTIVA DE UN COMPUESTO SEMEJANTE A ACICLOVIR EN TERAPIA CONJUNTIVA CON UNA CANTIDAD ANTIVIRAL EFECTIVA DE UN ANALOGO DE NUCLEOSIDO DE 2''-VINILO SUSTITUIDO.
ES94900549T 1992-12-03 1993-11-03 Composiciones que contienen compuestos analogos al aciclovir y analogos nucleosidicos sustituidos por vinilo en la posicion 2' utilizados en el tratamiento de infecciones virales. Expired - Lifetime ES2105599T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US98475792A 1992-12-03 1992-12-03

Publications (1)

Publication Number Publication Date
ES2105599T3 true ES2105599T3 (es) 1997-10-16

Family

ID=25530838

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94900549T Expired - Lifetime ES2105599T3 (es) 1992-12-03 1993-11-03 Composiciones que contienen compuestos analogos al aciclovir y analogos nucleosidicos sustituidos por vinilo en la posicion 2' utilizados en el tratamiento de infecciones virales.

Country Status (17)

Country Link
EP (1) EP0671918B1 (es)
JP (1) JPH08503942A (es)
KR (1) KR100297568B1 (es)
AT (1) ATE153533T1 (es)
AU (1) AU678789B2 (es)
CA (1) CA2150671C (es)
DE (1) DE69311135T2 (es)
DK (1) DK0671918T3 (es)
ES (1) ES2105599T3 (es)
GR (1) GR3024289T3 (es)
HU (1) HUT72604A (es)
IL (1) IL107818A (es)
MX (1) MX9307639A (es)
NO (1) NO952212L (es)
NZ (1) NZ258015A (es)
WO (1) WO1994012188A1 (es)
ZA (1) ZA938915B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2768295A (en) * 1994-07-11 1996-02-09 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3275061D1 (en) * 1982-02-12 1987-02-19 Ens Bio Logicals Inc Anti-viral compositions
IT1170232B (it) * 1983-10-31 1987-06-03 Anna Gioia Stendardi Composizioni terapeutiche ad attivita' antivirale
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
CA2002648C (en) * 1988-11-15 2000-02-29 James R. Mccarthy 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
EP0468119A1 (en) * 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
EP0477871A3 (en) * 1990-09-28 1992-12-02 Nippon Kayaku Kabushiki Kaisha Antiviral composition, containing guanine derivatives

Also Published As

Publication number Publication date
DK0671918T3 (da) 1997-06-16
DE69311135D1 (de) 1997-07-03
GR3024289T3 (en) 1997-10-31
IL107818A (en) 2000-01-31
ATE153533T1 (de) 1997-06-15
WO1994012188A1 (en) 1994-06-09
DE69311135T2 (de) 1997-09-25
MX9307639A (es) 1994-06-30
CA2150671A1 (en) 1994-06-09
AU5549594A (en) 1994-06-22
IL107818A0 (en) 1994-04-12
JPH08503942A (ja) 1996-04-30
HUT72604A (en) 1996-05-28
NO952212D0 (no) 1995-06-02
KR950703976A (ko) 1995-11-17
NZ258015A (en) 1997-01-29
NO952212L (no) 1995-06-02
CA2150671C (en) 2000-12-26
EP0671918A1 (en) 1995-09-20
KR100297568B1 (ko) 2001-11-14
AU678789B2 (en) 1997-06-12
ZA938915B (en) 1994-08-02
EP0671918B1 (en) 1997-05-28
HU9501627D0 (en) 1995-08-28

Similar Documents

Publication Publication Date Title
TW371660B (en) Therapeutic nucleosides a purine carbocyclic nucleosides for treatment of HIV and HBV infections
MY104043A (en) Therapeutic nucleosides.
ES2157929T3 (es) Beta-d-dioxolano-nucleosidos enantiomeramente puros.
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
ATE115958T1 (de) Nukleoside und nukleosid-analoge, pharmazeutische zusammensetzung und verfahren für die herstellung der bestandteile.
CO4970691A1 (es) Terapia en combinacion para erradicar vhc-arn detectable en pacientes que padecen infeccion de hepatitis c cronica
ES2194902T3 (es) L-nucleosidos para el tratamiento del virus de la hepatitis b y el virus de epstein barr.
MY130035A (en) Antiviral compounds
GB9110874D0 (en) Medicaments
UA40589C2 (uk) Спосіб лікування людини, що страждає від вірусної інфекції, фармацевтична композиція, комбінація речовин для отримання ліків та фармацевтична комбінація
KR900701282A (ko) 심장 또는 뇌의 허혈성 질환의 치료, 예방제
ATE157252T1 (de) 3'-azido-2',3'-dideoxy-5-methylcytidin enthaltende antivirale zusammensetzungen
KR950701638A (ko) 푸린 동족체의 항비루스성 포스폰산 유도체(Antiviral phosphonic acid derivatives of purine analogues)
ES2130246T3 (es) Nucleosidos terapeuticos de la serie 2',3'-didesoxi-3'-fluoro-purina.
MY105855A (en) Therapeutic nucleotides.
MX9301922A (es) Composiciones para el tratamiento de infeccion y enfermedad ocasionadas por el virus de hepatitis b (hbv).
ES2105599T3 (es) Composiciones que contienen compuestos analogos al aciclovir y analogos nucleosidicos sustituidos por vinilo en la posicion 2' utilizados en el tratamiento de infecciones virales.
ATE183508T1 (de) Therapeutische nukleoside
MX9202634A (es) Uso de analogos de nucleosido de 1,3-oxatiolano en el tratamiento de hepatitis b.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 671918

Country of ref document: ES